Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Orion Oyj Record 2025 Results Put Board Changes And Valuation In Focus
Orion Oyj Record 2025 Results Put Board Changes And Valuation In Focus
Simply Wall St
Sun, February 15, 2026 at 10:08 AM GMT+9 2 min read
In this article:
ORINF
-2.89%
ORINY
-0.49%
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
For investors watching the Nordic pharmaceuticals space, Orion Oyj sits at the intersection of patented medicines, generics and animal health, supported by an active R&D engine. The 2025 records in net sales and operating profit, together with milestone income from partnerships, indicate that Orion’s commercial portfolio and pipeline activities are both contributing to the business. These developments come at a time when larger pharma peers are also relying on R&D and alliances to support product pipelines.
Board changes alongside record results draw attention to how Orion Oyj plans its next phase, from capital allocation to partnership strategy. As the company heads into the AGM, shareholders and other stakeholders may focus on how the refreshed Board will oversee R&D priorities, potential future deals and overall governance of HLSE:ORNBV.
Stay updated on the most important news stories for Orion Oyj by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Orion Oyj.
HLSE:ORNBV 1-Year Stock Price Chart
Does the team leading Orion Oyj have what it takes? See our full breakdown of the management team’s track record and compensation.
Quick Assessment
There is only one way to know the right time to buy, sell or hold Orion Oyj. Head to Simply Wall St’s company report for the latest analysis of Orion Oyj’s Fair Value.
Key Considerations
Dig Deeper
For the full picture including more risks and rewards, check out the complete Orion Oyj analysis. Alternatively, you can check out the community page for Orion Oyj to see how other investors believe this latest news will impact the company’s narrative.
_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._
Companies discussed in this article include ORNBV.HE.
Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_
Terms and Privacy Policy
Privacy Dashboard
More Info